Sign up Australia
Proactive Investors - Run By Investors For Investors

Pyxus International rockets after its indirect subsidiary receives a cannabis cultivation license from Health Canada

The license permits Goldleaf Pharm to begin cultivating medicinal cannabis at its large Simcoe, Ontario facility
A man working in a cannabis facility
North Carolina-based Pyxus offers products in the leaf tobacco, e-Liquids, industrial hemp and legal cannabis industries

Shares of Pyxus International Inc (NYSE:PYX) soared Tuesday after the North Carolina agriculture company announced that its indirect Canadian subsidiary, Goldleaf Pharm Inc, received a cultivation license from Health Canada.

Pyxus International stock shot up nearly 24% to $28.72.

The Access to Cannabis for Medical Purposes Regulations (ACMPR) cultivation license permits Goldleaf Pharm to begin cultivating medicinal cannabis at its Simcoe, Ontario facility.

"This is an important step, and an exciting time, for us at Goldleaf Pharm," Goldleaf Pharm co-founder Larry Huszczo, said in a statement.

READ: Criticality partners with Pyxus to bring industrial hemp extraction to North Carolina

"We have a state of the art 20,000 square foot indoor growing facility, and recently acquired 20-acres of adjacent property, giving us the ability to expand to more than 700,000 square feet of production space to cultivate cannabis. I am very proud of our team, which has worked diligently to meet Health Canada's requirements," he added.

Goldleaf Pharm is a subsidiary of Pyxus' indirect Canadian subsidiary, FIGR Inc. FIGR’s Charlottetown subsidiary, Canada's Island Garden also received a nod from Health Canada to sell medicinal cannabis oils.

Canada's Island Garden previously announced a supply agreement with the province of Prince Edward Island for 1,000 kilograms of cannabis products.

READ: Tobacco player Alliance One International turns over a new (and greener) leaf

Pyxus International recently changed its name from Alliance One International, joining the ranks of the few other US-listed cannabis companies.

The North Carolina company offers products in the leaf tobacco, e-Liquids, industrial hemp and legal cannabis industries.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Join our Crypto, Blockchain and Cannabis Telegram group here
View full PYX profile View Profile

Pyxus International Inc Timeline

Related Articles

cannabis
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
1539364967_Cannabis-plant.jpg
October 10 2018
Management behind ICC International Cannabis Corp has a clear buy, build and sell strategy

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use